Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Xenetic Biosciences Inc (XBIO)

1.258   -0.042 (-3.23%) 08-07 13:46
Open: 1.3 Pre. Close: 1.3
High: 1.3 Low: 1.21
Volume: 164,793 Market Cap: 8M
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and novel oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. The company is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.331 - 1.339 1.339 - 1.346
Low: 1.243 - 1.251 1.251 - 1.258
Close: 1.288 - 1.301 1.301 - 1.313

Technical analysis

as of: 2020-08-07 1:31:58 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.72     One year: 2.10
Support: Support1: 0.95    Support2: 0.79
Resistance: Resistance1: 1.48    Resistance2: 1.80
Pivot: 1.25
Moving Average: MA(5): 1.25     MA(20): 1.20
MA(100): 0.97     MA(250): 1.19
MACD: MACD(12,26): 0.05     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 32.26     %D(3): 32.56
RSI: RSI(14): 54.67
52-week: High: 2.10  Low: 0.44  Change(%): -41.4
Average Vol(K): 3-Month: 65901  10-Days: 65833

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
XBIO has closed above bottom band by 49.5%. Bollinger Bands are 31.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 06 Aug 2020
Is a Correction Looming Ahead? Xenetic Biosciences, Inc. (XBIO) - The News Heater

Thu, 06 Aug 2020
Is Now the Time to Invest in Xenetic Biosciences Inc. (NASDAQ:XBIO)? - The Oracle Dispatch

Thu, 06 Aug 2020
Xenetic Biosciences Inc. (XBIO) market price of $1.31 offers the impression of an exciting value play - The InvestChronicle

Tue, 04 Aug 2020
What is the Forecast Price for Xenetic Biosciences Inc (XBIO) Stock? - InvestorsObserver

Thu, 30 Jul 2020
Xenetic Biosciences, Inc. Strengthens Scientific Advisory Board with Two Key Appointments - BioSpace

Wed, 22 Jul 2020
How Does Xenetic Biosciences Inc (XBIO) Stock Rank on Wall Street? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 6
Shares Float (M) 5
% Held by Insiders 14.72
% Held by Institutions 7.43
Shares Short (K) 350
Shares Short P. Month (K) 302

Stock Financials

EPS -3.334
EPS Est This Year -0.890
EPS Est Next Year -1.150
Book Value (p.s.) 2.580
Profit Margin
Operating Margin -11389.39
Return on Assets (ttm) -28.3
Return on Equity (ttm) -91.1
Qtrly Rev. Growth
Gross Profit (p.s.) 0.003
Sales Per Share 0.012
EBITDA (p.s.) -1.338
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.37
PEG Ratio
Price to Book value 0.48
Price to Sales 105.78
Price to Cash Flow -1.27

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.